Chemoinformaics analysis of Arabinosyl-Alpha-D-Galactosyl-D-Glucose
Molecular Weight | 474.412 | nRot | 8 |
Heavy Atom Molecular Weight | 444.172 | nRig | 13 |
Exact Molecular Weight | 474.158 | nRing | 2 |
Solubility: LogS | -0.479 | nHRing | 2 |
Solubility: LogP | -3.062 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 15 | No. of Arom Bond | 0 |
nHA | 15 | APOL | 60.4238 |
nHD | 12 | BPOL | 34.4362 |
QED | 0.156 |
Synth | 5.272 |
Natural Product Likeliness | 1.847 |
NR-PPAR-gamma | 0.001 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.988 |
HIA | 0.989 |
CACO-2 | -6.288 |
MDCK | 0.000270505 |
BBB | 0.294 |
PPB | 0.180991 |
VDSS | 0.249 |
FU | 0.580396 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.003 |
CYP2c19-inh | 0.006 |
CYP2c19-sub | 0.042 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.039 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.056 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0 |
CL | 0.847 |
T12 | 0.788 |
hERG | 0.289 |
Ames | 0.06 |
ROA | 0.006 |
SkinSen | 0.034 |
Carcinogencity | 0.003 |
EI | 0.013 |
Respiratory | 0.019 |
NR-Aromatase | 0.031 |
Antiviral | Yes |
Prediction | 0.708954 |